Sector Focus Oxford Finance has deep expertise in life sciences, healthcare, business services, and software and technology, with a proven track record of financing growth for hundreds of borrowers. This creates opportunities to cross-sell flexible debt solutions to biotech, medtech, SaaS, and other growth-stage firms seeking capital to fund R&D, scale operations, or pursue acquisitions.

ABL Growth The newly launched Asset-Based Lending division with AMX Logistics signals a deliberate push into asset-backed finance for asset-heavy sectors such as logistics, transportation, and manufacturing, expanding the range of clients and deal structures available.

Venture Debt Edge Oxford has demonstrated appetite for venture debt and non-dilutive financing, including financings for high-growth biotech and fintech companies, positioning them as a partner for firms seeking non-dilutive capital to accelerate growth.

Global Reach A history of cross-border and international deals—spanning UK and US/Canada—indicates capability to support global expansion with multi-jurisdiction financing.

Flexible Capital With scalable facilities and a proven track record across diverse industries, Oxford can serve mid-market companies needing flexible debt to fuel growth, capex, and strategic initiatives.